How would you manage OCPs in a patient who develops a VTE while on treatment?

In a patient with a medical or personal indication to induce oligomenorrhea/amenorrhea, how would you manage OCP therapy if a patient develops a VTE during treatment course? Would you considering continuing estrogen-progestin contraception if anticoagulation is continued? Would you switch to a lower dose estrogen formulation? Would you switch to a progestin-only method (including levonorgestrel-releasing IUD)?